Regenerative Medical Technology Group Inc.

Regenerative Medical Technology Group Inc. operates as a vertically integrated provider in the regenerative medicine industry through its subsidiary, Global Stem Cells Group. The company develops, manufactures, and distributes biologics and therapeutics, including exosomes, mesenchymal stem cells, and peptide products under the Cellgenic brand. In addition to manufacturing consumables and clinical equipment, it offers professional medical training, certifications, and educational events via the International Society for Stem Cell Applications. The business also provides clinical treatments and digital healthcare software platforms, serving physicians, medical providers, affiliated clinics, and patients seeking regenerative and longevity therapies.

The company operates internationally, deriving its customer revenue outside the United States with activities across Latin America, the Middle East, Southeast Asia, South Asia, and Europe. Its physical facilities include a flagship clinical and research center in Cancún, Mexico, featuring dedicated procedure suites and a biologics processing laboratory, alongside a regulatory and production presence in Argentina. Executive offices are located in Boca Raton, Florida.

Summary of the business section of Regenerative Medical Technology's latest annual report, written by StockData.

“As of December 31, 2022, the Company had 1 full-time employees.”